Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus reuteri for NEC prevention in VLBW infants
NCT01531179Phase 3Completed
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of lactobacillus reuteri in necrotizing enterocolitis (NEC), sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital. Started Feb 2012; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT01531179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531179.